Effects of catecholamines on the inflammatory response

Sepsis

Volumn 4, Issue 2, 2001, Pages 159-167

  Van der Poll, T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Catecholamines; Coagulation; Cytokines; Neutrophils; Sepsis; Tumor necrosis factor

Indexed keywords

CATECHOLAMINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; ISOPRENALINE; PHENYLEPHRINE; TUMOR NECROSIS FACTOR; VASOACTIVE AGENT;

CARDIOVASCULAR RESPONSE; CATECHOLAMINE RELEASE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MOLECULAR INTERACTION; REVIEW; SEPSIS;

EID: 0035002571     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011463006351     Document Type: Review

References (69)

1. Sepsis: A new hypothesis for pathogenesis of the disease process
2. Treating patients with severe sepsis
3. Pharmacological management of shock: Support of the cardiovascular system
4. Hormonal control of metabolism in trauma and sepsis
5. Cytokines and anti-cytokines in the pathogenesis of sepsis
6. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis
7. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
8. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia
9. Role of interferon-γ in experimental gram-negative sepsis
10. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice
11. The role of cytokines in the pathogenesis of pneumonia
12. Role of cytokines in pulmonary antimicrobial defense
13. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
14. IL-10 controls IFN-γ and TNF production during experimental endotoxemia
15. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance
16. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia
17. Interleukin 10 impairs host defense in murine pneumococcal pneumonia
18. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans
19. Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates
20. Endocrine and metabolic effects of interleukin-6 in humans
21. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists
22. The role of cAMP regulation in controlling inflammation
23. Beta-adrenergic receptors and their regulation
24. β adrenergic regulation of gene expression of tumor necrosis factor-α in human macrophages
25. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood
26. Epinephrine inhibits tumor necrosis factor α and potentiates interleukin 10 release during human endotoxemia
27. Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro
28. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor
29. Adrenaline enhances LPS-induced IL-10 synthesis: Evidence for protein kinase A-mediated pathway
30. Regulation of interleukin-10 production by β-adrenergic agonists
31. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
32. β-adrenergic modulation of human type-1/type-2 cytokine balance
33. 2
34. 2 is a potent inhibitor of human interleukin 12 production
35. Epinephrine inhibits endotoxin-induced interleukin-1 production: Roles of tumor necrosis factor-α and IL-10
36. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver
37. Catecholamines upregulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells
38. Epinephrine inhibits the production of interferon-γ and interleukin 12 in whole blood stimulated with endotoxin
39. β2-agonists prevent Th1 development by selective inhibition of interleukin 12
40. Differential expression of the β2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help
41. Salmeterol inhibits interferon-gamma and interleukin-4 production by human peripheral blood mononuclear cells
42. Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone
43. Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets
44. β2-adrenergic activation enhances interleukin-8 production by human monocytes
45. β-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release
46. Anti-inflammatory activity of salmeterol: Down-regulation of cytokine production
47. Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α and β adrenergic drugs in mice
48. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia
49. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat
50. Stimulation of β-adrenoreceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice
51. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury
52. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoreceptor mediated mechanism
53. Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C
54. Epinephrine attenuates downregulation of monocyte tumor necrosis factor receptors during human endotoxemia
55. Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation
56. Mechanisms of lysosomal enzyme release from human leukocytes
57. Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine
58. β adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation
59. Inhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils
60. Beta2-agonist-induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and Mac-1 expression or with impairment of polymorphonuclear leukocyte antibacterial activity
61. Stress hormones modulate neutrophil and lymphocyte activity in vitro
62. Increased neutrophil mobilization and decreased chemotaxis during cortisol and epinephrine infusions
63. LPS-induced blood neutrophilia is inhibited by alpha-1-adrenoreceptor antagonists: A role for catecholamines
64. Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation
65. Pathogenesis of DIC in sepsis
66. Epinephrine exerts anticoagulant effects during human endotoxemia
67. Fibrinolytic response during exercise and epinephrine infusion in the same subjects
68. In vitro stimulation of plasminogen activator release from vein walls by adrenaline
69. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism